Patent ID: 9688767
Date: 2017-06-27
CPC Classifications: A61K,C07K,C12Q,G01N

Claim:
1. A method for predicting the survival time of a patient suffering from myocardial infarction or the recurrence of a myocardial infarction in a patient who has suffered from a myocardial infarction and treating said patient, comprising the steps of i) determining the expression level of B cell activating factor (BAFF) in a sample from said patient, ii) comparing said expression level with a control value, wherein said control value is based on BAFF levels in a collection of samples from patients suffering from myocardial infarction, or based on BAFF levels in a collection of samples from healthy subjects, iii) providing a good prognosis of the survival time or a low risk of the recurrence of a myocardial infarction when the expression level is lower than the control value, or providing a poor prognosis of the survival time or a high risk of the recurrence of a myocardial infarction when the expression level is higher than the control value, and iv) administering a therapeutically effective amount of an anti-CD20 antibody to said patient when a poor prognosis is provided in step iii), wherein the therapeutically effective amount is sufficient to treat said patient.